Citi Research upgrades Symrise to “buy” on low valuation and resilient outlook

1 week ago 9
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. Citi Research upgrades Symrise to “buy” on low valuation and resilient outlook

Related

UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Inva

UroGen Announces Updated 18-Month Duration of Response (DOR)...

3 hours ago 1
US could restrict Mexican livestock imports over screwworm worry, official says

US could restrict Mexican livestock imports over screwworm w...

3 hours ago 1
Young Canadians favor Conservatives in election despite Trump threat

Young Canadians favor Conservatives in election despite Trum...

3 hours ago 1
RIGHT SIDEBAR TOP AD

Trending

1. noah kahan
2. aj minter
3. san diego wave vs chicago stars
4. max brosmer
5. jarren duran
6. russell dickerson
7. chris gutierrez
8. mn wild
9. aaron gordon
10. savannah bananas

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

2 weeks ago 77
Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

2 weeks ago 77
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

2 weeks ago 67
From classifying immigrants as dead to deportation: A guide to actions on Trump immigration policies

From classifying immigrants as dead to deportation: A guide ...

2 weeks ago 66
Biden reemerges on the attack, but doesn’t mention Trump

Biden reemerges on the attack, but doesn’t mention Trump

1 week ago 63
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved